02.22.16
Aldevron, a provider of products and contract manufacturing services for the pharmaceutical and biotechnology industries, has appointed Jenny Stafford as vice president and general manager. Ms. Stafford’s responsibilities include overseeing the company’s manufacturing and client relations operations in Fargo, ND.
“We are pleased to have Ms. Stafford assume the newly created position of vice president and general manager,” said Michael Chambers, president and chief executive officer, Aldevron. “Ms. Stafford has distinguished herself over the past 2.5 years at Aldevron as director of quality and regulatory by building an outstanding quality organization, leading the company’s compliance efforts, and directly supporting our clients’ needs. Her expertise and experience will play a crucial role as we grow the company to serve the expanding biologics manufacturing market.”
Prior to Aldevron, Ms. Stafford held positions of increasing responsibility at LifeCell Corporation, Merck Pharmaceuticals and PRACS Institute. Her responsibilities included managing quality systems for compliance with international GMP and GLP regulations in the pharmaceutical, medical device, and human tissue production industries.
“We are pleased to have Ms. Stafford assume the newly created position of vice president and general manager,” said Michael Chambers, president and chief executive officer, Aldevron. “Ms. Stafford has distinguished herself over the past 2.5 years at Aldevron as director of quality and regulatory by building an outstanding quality organization, leading the company’s compliance efforts, and directly supporting our clients’ needs. Her expertise and experience will play a crucial role as we grow the company to serve the expanding biologics manufacturing market.”
Prior to Aldevron, Ms. Stafford held positions of increasing responsibility at LifeCell Corporation, Merck Pharmaceuticals and PRACS Institute. Her responsibilities included managing quality systems for compliance with international GMP and GLP regulations in the pharmaceutical, medical device, and human tissue production industries.